Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech

Revive Therapeutics (OTC:RVVTF) said today that it inked a research agreement with the University of Wisconsin-Madison to develop a drug delivery technology for cannibinoids. The research program, led by Jess Reed, is slated to evaluate chitosan-tannin composite biomaterial as a delivery mechanism for cannabinoids. Therapeutic biomaterials made from a composite of chitosan and tannin include nanoparticles, hydrogels, bio-foams, bio-gels or a liposomal coating. Get the full story at our sister site, Drug Delivery Business News. The post Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Pain Management Research & Development Wall Street Beat revivetherapeutics University of Wisconsin-Madison Source Type: news